468 related articles for article (PubMed ID: 15471963)
1. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer.
Barclay WW; Woodruff RD; Hall MC; Cramer SD
Endocrinology; 2005 Jan; 146(1):13-8. PubMed ID: 15471963
[TBL] [Abstract][Full Text] [Related]
2. Differential impact of paired patient-derived BPH and normal adjacent stromal cells on benign prostatic epithelial cell growth in 3D culture.
Chen W; Pascal LE; Wang K; Dhir R; Sims AM; Campbell R; Gasper G; DeFranco DB; Yoshimura N; Wang Z
Prostate; 2020 Oct; 80(14):1177-1187. PubMed ID: 32659026
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
Giri D; Ittmann M
Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
[TBL] [Abstract][Full Text] [Related]
5. Role of the stromal microenvironment in carcinogenesis of the prostate.
Cunha GR; Hayward SW; Wang YZ; Ricke WA
Int J Cancer; 2003 Oct; 107(1):1-10. PubMed ID: 12925950
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
[TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
Wang W; Zhang X; Mize GJ; Takayama TK
Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
[TBL] [Abstract][Full Text] [Related]
8. Role of stroma in carcinogenesis of the prostate.
Cunha GR; Hayward SW; Wang YZ
Differentiation; 2002 Dec; 70(9-10):473-85. PubMed ID: 12492490
[TBL] [Abstract][Full Text] [Related]
9. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
[TBL] [Abstract][Full Text] [Related]
10. Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell.
Kim JH; Kim SS; Han IH; Sim S; Ahn MH; Ryu JS
Prostate; 2016 Nov; 76(15):1431-44. PubMed ID: 27325623
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth.
Timme TL; Truong LD; Slawin KM; Kadmon D; Park SH; Thompson TC
Microsc Res Tech; 1995 Mar; 30(4):333-41. PubMed ID: 7541677
[TBL] [Abstract][Full Text] [Related]
12. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture.
Boudon C; Rodier G; Lechevallier E; Mottet N; Barenton B; Sultan C
J Clin Endocrinol Metab; 1996 Feb; 81(2):612-7. PubMed ID: 8636277
[TBL] [Abstract][Full Text] [Related]
13. Primary prostate stromal cells modulate the morphology and migration of primary prostate epithelial cells in type 1 collagen gels.
Hall JA; Maitland NJ; Stower M; Lang SH
Cancer Res; 2002 Jan; 62(1):58-62. PubMed ID: 11782359
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium.
Pruitt FL; He Y; Franco OE; Jiang M; Cates JM; Hayward SW
Prostate; 2013 Apr; 73(5):476-88. PubMed ID: 22996917
[TBL] [Abstract][Full Text] [Related]
17. Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6.
Degeorges A; Tatoud R; Fauvel-Lafeve F; Podgorniak MP; Millot G; de Cremoux P; Calvo F
Int J Cancer; 1996 Oct; 68(2):207-14. PubMed ID: 8900430
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
Matsuda T; Fujime M; Suda K
Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
[TBL] [Abstract][Full Text] [Related]
19. Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2.
Wu Q; Zhou Y; Chen L; Shi J; Wang CY; Miao L; Klocker H; Park I; Lee C; Zhang J
J Endocrinol; 2007 Oct; 195(1):89-94. PubMed ID: 17911400
[TBL] [Abstract][Full Text] [Related]
20. Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner.
Wu Q; Shi J; Chen L; Wang CY; Park I; Lee C; Zhang J
BJU Int; 2008 Feb; 101(4):497-502. PubMed ID: 18190643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
